Scorpius Holdings Inc (FRA:1HB0)
€ 10 0 (0%) Market Cap: 2.63 Mil Enterprise Value: 15.93 Mil PE Ratio: 0 PB Ratio: 0.02 GF Score: 37/100

Heat Biologics Inc Investor And Media Livestream Event Transcript

Apr 19, 2022 / 02:30PM GMT
Release Date Price: €570 (+11.63%)
Jeff Wolf
Nighthawk Biosciences, Inc. - Founder and CEO

Thank you. I am Jeff Wolf, CEO of Heat Biologics, and thank you for joining us from the Purple Masque Theatre in Manhattan, Kansas today.

So, you've probably heard our announcement yesterday about our commercial scale facility here in Kansas, and today, we'll touch on that. But we'll also be announcing some important new developments later as well.

Over the past 18 months, we've built a powerful drug discovery engine in our Skunkworx subsidiary. We've built the Scorpion subsidiary to deliver world-class biomanufacturing, and we announced the acquisition of Elusys Therapeutics, a biodefense company which we intend to grow into a biodefense powerhouse.

Yesterday's announcement is part of our broad vision to build an ecosystem to move drugs from the lab to the people who need them as quickly and efficiently as possible. This empowers us to bring our ideas to life with efficient control, superior quality and uncharacteristic agility.

Ours is a unique model that starts with discovery at our Skunkworx subsidiary in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot